Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Malignant Melanoma

Free Subscription Articles published in BMC Cancer Retrieve available abstracts of 29 articles: HTML format Text format

Single Articles

December 2011
1. TELANG S , Rasku MA, Clem AL, Carter K, et al
   Phase II trial of the regulatory T cell-depleting agent, denileukin diftitox, in patients with unresectable stage IV melanoma.
   BMC Cancer. 2011;11:515.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
2. LABELLE-COTE M , Dusseault J, Ismail S, Picard-Cloutier A, et al
   Nck2 promotes human melanoma cell proliferation, migration and invasion in vitro and primary melanoma-derived tumor growth in vivo.
   BMC Cancer. 2011;11:443.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   August 2011
3. NEUMANN LC , Weinhausel A, Thomas S, Horsthemke B, et al
   EFS shows biallelic methylation in uveal melanoma with poor prognosis as well as tissue-specific methylation.
   BMC Cancer. 2011;11:380.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. MARTINEZ-CADENAS C , Bosch N, Penas L, Flores-Couce E, et al
   Malignant melanoma arising from a perianal fistula and harbouring a BRAF gene mutation: a case report.
   BMC Cancer. 2011;11:343.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. PERIC B , Zagar I, Novakovic S, Zgajnar J, et al
   Role of serum S100B and PET-CT in follow-up of patients with cutaneous melanoma.
   BMC Cancer. 2011;11:328.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   June 2011
6. BALJINNYAM E , Umemura M, Delorenzo MS, Xie LH, et al
   G betagamma subunits inhibit Epac-induced melanoma cell migration.
   BMC Cancer. 2011;11:256.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   May 2011
7. AVERY-KIEJDA KA , Bowden NA, Croft AJ, Scurr LL, et al
   P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation.
   BMC Cancer. 2011;11:203.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   April 2011
8. FOGARTY G , Morton RL, Vardy J, Nowak AK, et al
   Whole brain radiotherapy after local treatment of brain metastases in melanoma patients - a randomised phase III trial.
   BMC Cancer. 2011;11:142.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   February 2011
9. CHI Z , Li S, Sheng X, Si L, et al
   Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: A study of 522 consecutive cases.
   BMC Cancer. 2011;11:85.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   January 2011
10. RODRIGUEZ BL , Yu Z, Chung WG, Weiss R, et al
    Replicase-based plasmid DNA shows anti-tumor activity.
    BMC Cancer. 2011;11:110.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
11. YANG X , Ren GX, Zhang CP, Zhou GY, et al
    Neck dissection and post-operative chemotherapy with dimethyl triazeno imidazole carboxamide and cisplatin protocol are useful for oral mucosal melanoma.
    BMC Cancer. 2010;10:623.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
12. TEUTSCHBEIN J , Haydn JM, Samans B, Krause M, et al
    Gene expression analysis after receptor tyrosine kinase activation reveals new potential melanoma proteins.
    BMC Cancer. 2010;10:386.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
13. EL KHOURY D , Destouches D, Lengagne R, Krust B, et al
    Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice.
    BMC Cancer. 2010;10:325.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. THANGASAMY T , Sittadjody S, Mitchell GC, Mendoza EE, et al
    Quercetin abrogates chemoresistance in melanoma cells by modulating deltaNp73.
    BMC Cancer. 2010;10:282.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. ANDREU-PEREZ P , Hernandez-Losa J, Moline T, Gil R, et al
    Methylthioadenosine (MTA) inhibits melanoma cell proliferation and in vivo tumor growth.
    BMC Cancer. 2010;10:265.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. LEIDINGER P , Keller A, Borries A, Reichrath J, et al
    High-throughput miRNA profiling of human melanoma blood samples.
    BMC Cancer. 2010;10:262.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. BEDIN V , Adam RL, de Sa BC, Landman G, et al
    Fractal dimension of chromatin is an independent prognostic factor for survival in melanoma.
    BMC Cancer. 2010;10:260.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
18. EMMETT MS , Symonds KE, Rigby H, Cook MG, et al
    Prediction of melanoma metastasis by the Shields index based on lymphatic vessel density.
    BMC Cancer. 2010;10:208.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
19. KIM HS , Kim EK, Jun HJ, Oh SY, et al
    Noncutaneous malignant melanoma: a prognostic model from a retrospective multicenter study.
    BMC Cancer. 2010;10:167.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. LESINSKI GB , Zimmerer JM, Kreiner M, Trefry J, et al
    Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cells.
    BMC Cancer. 2010;10:142.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. LADSTEIN RG , Bachmann IM, Straume O, Akslen LA, et al
    Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma.
    BMC Cancer. 2010;10:140.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
22. BALIVADA S , Rachakatla RS, Wang H, Samarakoon TN, et al
    A/C magnetic hyperthermia of melanoma mediated by iron(0)/iron oxide core/shell magnetic nanoparticles: a mouse study.
    BMC Cancer. 2010;10:119.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. GUIMARAES FD , Andrade LF, Martins ST, Abud AP, et al
    In vitro and in vivo anticancer properties of a Calcarea carbonica derivative complex (M8) treatment in a murine melanoma model.
    BMC Cancer. 2010;10:113.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2010
24. MASCOLO M , Vecchione ML, Ilardi G, Scalvenzi M, et al
    Overexpression of Chromatin Assembly Factor-1/p60 helps to predict the prognosis of melanoma patients.
    BMC Cancer. 2010;10:63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
25. BRIGGS JJ , Haugen MH, Johansen HT, Riker AI, et al
    Cystatin E/M suppresses legumain activity and invasion of human melanoma.
    BMC Cancer. 2010;10:17.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. MERKEL CA , da Silva Soares RB, de Carvalho AC, Zanatta DB, et al
    Activation of endogenous p53 by combined p19Arf gene transfer and nutlin-3 drug treatment modalities in the murine cell lines B16 and C6.
    BMC Cancer. 2010;10:316.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. DE OLIVEIRA SI , Andrade LN, Onuchic AC, Nonogaki S, et al
    Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy.
    BMC Cancer. 2010;10:200.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. KWON HK , Hwang JS, So JS, Lee CG, et al
    Cinnamon extract induces tumor cell death through inhibition of NFkappaB and AP1.
    BMC Cancer. 2010;10:392.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. PATTEN SG , Adamcic U, Lacombe K, Minhas K, et al
    VEGFR2 heterogeneity and response to anti-angiogenic low dose metronomic cyclophosphamide treatment.
    BMC Cancer. 2010;10:683.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: